EURACTIV PR

An easy way of publishing your relevant EU press releases.

Medicines for Europe

Press Releases of this organisation

TITLE ORGANISATION DATE TOPIC
Off patent medicines essential for a fairer, healthier, and sustainable Europe says President Christoph Stoller Medicines for Europe Fri, 04/30/2021 Health & Consumers
European patients need improved access to biosimilar medicines Medicines for Europe Thu, 04/22/2021 Health & Consumers
New report assesses progress on biosimilar medicine policies across Europe Medicines for Europe Tue, 03/30/2021 Health & Consumers
EU industrial policy can dramatically improve medicines manufacturing resilience and security of supply Medicines for Europe Wed, 03/17/2021 Health & Consumers
New report reveals need for pricing and reimbursement and procurement reforms to ensure patient access and healthcare sustainability Medicines for Europe Mon, 03/01/2021 Health & Consumers
Smart policies will encourage more critical medicines manufacturing in Europe Medicines for Europe Fri, 02/26/2021 Health & Consumers
EU must address barriers to continuous off-patent innovation and grasp opportunity for patients and healthcare Medicines for Europe Tue, 02/23/2021 Health & Consumers
A new medicines trade and health security agenda for the European Commission Medicines for Europe Fri, 02/19/2021 Health & Consumers
No further excuse to delay digital regulatory infrastructure for medicines after COVID-19 pandemic Medicines for Europe Fri, 02/19/2021 Health & Consumers
Smarter use of generic, biosimilar and value added medicines will ensure equitable access to cancer care Medicines for Europe Thu, 02/04/2021 Health & Consumers
AESGP, EFPIA and Medicines for Europe reflections on the European Medicines Agency, the Heads of Medicines Agencies and the European Commission “Key principles for the use of electronic product information for EU medicines” Medicines for Europe Wed, 02/03/2021 Health & Consumers
Window of opportunity to enhance EU regulatory systems wide open as EU pharma strategy prioritises stronger EU networks Medicines for Europe Tue, 01/19/2021 Health & Consumers
EU digital strategy requires investments in the digitalisation of Europe’s medicines regulatory agencies to succeed Medicines for Europe Fri, 01/15/2021 Health & Consumers
EU pharma strategy success depends on access to generic, biosimilar and value added medicines Medicines for Europe Wed, 11/25/2020 Health & Consumers
European Health Union – first step to greater EU solidarity in health crisis situations Medicines for Europe Wed, 11/11/2020 Health & Consumers
Failure to launch: white paper explores the role of inappropriate use of IP in blocking access to generic and biosimilar medicines Medicines for Europe Thu, 11/05/2020 Health & Consumers
Now or never: pragmatism & ambition needed in EU pharma strategy to deliver on Europe’s medicines manufacturing Medicines for Europe Wed, 10/07/2020 Health & Consumers
Decisive action on medicines shortages should be included in pharmaceutical and industrial strategies Medicines for Europe Fri, 09/18/2020 Health & Consumers
COVID-19 a lightning rod for major overhaul of EU pharmaceutical policy Medicines for Europe Thu, 07/09/2020 Health & Consumers
IQVIA Institute Scorecards show biosimilar medicines offer win for patients, policymakers and healthcare systems across Europe Medicines for Europe Tue, 06/30/2020 Health & Consumers
EU Pharmaceutical Strategy Roadmap: high time to improve patient access to medicines and to apply the lessons from COVID-19 Medicines for Europe Thu, 06/04/2020 InfoSociety
EMA clarifies no scientific evidence to deter use of ibuprofen to manage coronavirus symptoms Medicines for Europe Wed, 03/18/2020 Health & Consumers
Medicines for Europe statement on COVID-19 (‘coronavirus’) Medicines for Europe Fri, 03/13/2020 Health & Consumers
Protecting health: Active generic and biosimilar policies central to EU pharmaceutical strategy Medicines for Europe Tue, 03/03/2020 Health & Consumers
The European Medicines Verification System (EMVS) celebrates 1 year of successful operation across Europe Medicines for Europe Fri, 02/07/2020 Health & Consumers, InfoSociety
Time to modernise the eu pharmaceutical regulatory framework to deliver on access Medicines for Europe Thu, 01/30/2020 Health & Consumers, InfoSociety
Smart Pharmacovigilance Essential for Patient Safety Medicines for Europe Wed, 01/29/2020 Health & Consumers
Generic & biosimilar medicines pivotal for safe, effective and affordable access to medicines in Europe Medicines for Europe Thu, 11/28/2019 Health & Consumers
‘Health revolution’: when smart innovation benefits patients Medicines for Europe Thu, 11/21/2019 Health & Consumers
Medicines for Europe, APOGEN and Fresenius Kabi hold Open Industry Day in Portugal Medicines for Europe Thu, 11/14/2019 Health & Consumers

Pages